A new lawsuit has been filed in the California court on 21st of September 2012 strengthens the notion that Actos has a direct link with bladder cancer. According to the lawsuit filed by Jennie Tapia a resident of California she had been using Actos for a prolonged period as a treatment for the condition Type II diabetes. However, it was not earlier than November 2010 when her doctor found she developed a bladder cancer.

In her lawsuit the plaintiff and her injury lawyer have framed the charges of negligence, breach of warranties, concealing of information and misrepresentation of study data against the manufacturer of the drug and have seek compensatory and punitive damages for the harassment that she suffered. Asides, the plaintiff has accused the company of hiding relevant information about the drug. Had she knew it earlier, she wouldn’t have taken this medicine, said the attorney for the plaintiff. She also added that she has suffered many associated permanent injuries and emotional distress due to the medicine in question and viewing the long term consequences of the incidence and the degree of harassments that she had suffered she is entitled to receive all the monetary compensation along with medical losses that she incurred all the way through.

What is Actos

It is important to underline here that Actos is a drug manufactured by Takeda Pharma to treat the condition of Type II diabetes a condition which appears when the level of glucose can’t be controlled by the body. The drug is a Pioglitazone which is sold as single-ingredient product under the brand-name Actos.

Some Basic Facts about Actos:

  • The diabetes drug Actos is commonly sold in combination with glimepiride and metformin
  •  The drug is manufactured and marketed by the pharmaceutical giant Takeda Pharma Inc.
  • The drug is a prevalent across the globe and according to various reports it is estimated that from January 2010 through October 2010, approximately 2.3 million patients filled a prescription for this product
  • The drug is used to regulate the level of blood sugar in adults with type 2 diabetes mellitus.

Despite its wide acceptance and beneficial outcomes recent studies have shown that prolonged and extended use of the drug could led to cancer of bladder which raised the eyebrows of the FDA and other medical practitioners. These reports have confirmed that people who are using this unsafe drug are more prone to the disease and are 40% more vulnerable to bladder cancer compared to other drugs available in the market. Some of the associated symptoms that people can experience should they happen to take this drug for extended periods are:

  • Increased, intense and acute urge to urinate
  • Passage of blood with urine